`
`
`
`
`
`
`
`Filed on behalf of Patent Owners Bristol-Myers Squibb Company and Pfizer Inc.
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS INC.,
`
`Petitioner,
`
`v.
`
`BRISTOL-MYERS SQUIBB COMPANY and
`PFIZER INC.,
`
`Patent Owners.
`
`IPR2018-00892
`
`Patent No. 9,326,945
`
`
`PATENT OWNERS’ OPPOSITION TO PETITIONER’S MOTION TO
`FILE SUPPLEMENTAL INFORMATION PURSUANT TO
`37 C.F.R. § 42.123(a)
`
`
`
`
`
`
`
`
`
`
`
`TABLE OF CONTENTS
`
`INTRODUCTION ................................................................................ 1
`
`
`I.
`
`II. MATERIAL FACTS ............................................................................ 1
`
`III. LEGAL AUTHORITY ......................................................................... 2
`
`IV. PETITIONER SHOULD NOT BE ALLOWED TO REPLACE
`A PRIOR-ART REFERENCE AFTER INSTITUTION ..................... 3
`
`A.
`
`B.
`
`Petitioner’s Mistake Should Not Be Correctable via
`Supplemental Information and Allowing Correction
`Would Reduce the Efficiency of the Proceeding ....................... 3
`
`Patent Owners Have Been Prejudiced by Petitioner’s
`Mistake ....................................................................................... 4
`
`C.
`
`Petitioner Could Have Discovered Its Mistake Sooner ............. 5
`
`V.
`
`CONCLUSION ..................................................................................... 5
`
`
`
`– ii –
`
`
`
`I.
`
`INTRODUCTION
`
`Petitioner’s Ex. 1010 is not a prior-art reference, but a compilation
`
`consisting of the cover and publishing information of the fourth edition of Modern
`
`Pharmaceutics (“Rudnic”) and pages from the third edition. Petitioner now seeks
`
`to replace Ex. 1010 with Ex. 1042, which is an excerpt solely from the third
`
`edition. Although Petitioner requests entry of a completely new reference, it still
`
`has not carried its burden to show that any edition of Rudnic is a prior-art printed
`
`publication. That behavior has prejudiced Patent Owners, who were forced to file
`
`their Preliminary Response without knowing what Petitioner meant to rely on and
`
`have been hampered in their ability to contest the public availability of Rudnic.
`
`II. MATERIAL FACTS
`
`Patent Owners were served with the Petition and the related exhibits on
`
`April 5, 2018. Among the exhibits was Exhibit 1010, identified as “Rudnic et al.,
`
`‘Tablet Dosage Forms,’ in Modern Pharmaceutics, 4th ed., G.S. Banker and C.T.
`
`Rhodes, eds., Taylor & Francis Group, Boca Raton, FL, pp. 333-359 (2002).”
`
`Paper 2 at App. B. When Patent Owners obtained a copy of the fourth edition of
`
`Modern Pharmaceutics, it became clear that the pages referred to in the Petition
`
`and the Park Declaration did not correspond to the cited chapter. Although it was
`
`clear that something was wrong, Patent Owner had no way of knowing what. For
`
`example, the Petition and the Park Declaration may have correctly cited the fourth
`
`– 1 –
`
`
`
`edition but used the wrong page numbers, or they may have cited the proper page
`
`numbers of an unknown reference.
`
`In their July 18, 2018 Preliminary Response, Patent Owners questioned the
`
`public availability and authenticity of Ex. 1010, pointing out that it appeared to be
`
`“a compilation of multiple documents pieced together by Petitioner.” Paper 18 at
`
`2-3, 13 & n.3, 26 n.10, 40-45; Ex. 2019. In the three months following that filing,
`
`Petitioner did not seek to correct the Petition.
`
`After the Board instituted review on October 15, 2018, Patent Owners
`
`challenged the public availability of Rudnic in their Objections to Evidence.
`
`Petitioner served Patent Owners with supplemental evidence on November 9,
`
`2018. In those materials, for the first time, Petitioner claimed that the information
`
`on which it was relying was actually from the third edition of Rudnic.
`
`III. LEGAL AUTHORITY
`
`37 C.F.R. § 42.123(a) provides that supplemental information may be filed
`
`(1) if authorization to do so is requested within a month of institution and (2) if the
`
`information is relevant to a claim for which trial has been instituted. The Board
`
`may also consider whether allowing the supplemental information would comport
`
`with its statutory mandate to consider “‘the efficient administration of the Office[]
`
`and the ability of the Office to timely complete proceedings instituted under this
`
`chapter.’” Redline Detection, LLC v. Star Envirotech, Inc., 811 F.3d 435, 441-49
`
`– 2 –
`
`
`
`(Fed. Cir. 2015) (alteration in original) (quoting 35 U.S.C. § 316(b)). In particular,
`
`the Board can disallow submissions when the petitioner seeks to substantively
`
`change the grounds laid out in the petition after the preliminary response or the
`
`institution decision have pointed out weaknesses. Paper 22 at 7-9, Western Digital
`
`Corp. v. Spex Techs., Inc., IPR2018-00082 (P.T.A.B. July 23, 2018).
`
`IV. PETITIONER SHOULD NOT BE ALLOWED TO REPLACE A
`PRIOR-ART REFERENCE AFTER INSTITUTION
`A.
`
`Petitioner’s Mistake Should Not Be Correctable via Supplemental
`Information and Allowing Correction Would Reduce the
`Efficiency of the Proceeding
`
`“The provision for submitting supplemental information is not intended to
`
`offer a petitioner a routine avenue for bolstering deficiencies in a petition raised by
`
`a patent owner in a preliminary response. Nor should the proposed supplemental
`
`information change any grounds of unpatentability that were authorized in [a]
`
`proceeding or change the type of evidence initially presented in the Petition to
`
`support those grounds of unpatentability.” Paper 20 at 3, Merck Sharp & Dohme
`
`Corp. v. Microspherix LLC, IPR2018-00402 (P.T.A.B. Sept. 10, 2018).
`
`Rather, § 42.123(a) is typically used to submit additional information to
`
`show that a reference relied on in the petition is a printed publication. See, e.g.,
`
`Paper 28 at 3-7, Blue Coat Sys., Inc. v. Finjan, Inc., IPR2016-01444 (P.T.A.B. Oct.
`
`23, 2017); Paper 37 at 2-3, Palo Alto Networks, Inc. v. Juniper Networks, Inc.,
`
`IPR2013-00369 (Feb. 5, 2014). The Board itself suggested that Petitioner use a
`
`– 3 –
`
`
`
`supplemental information submission to establish Rudnic’s publication date. Paper
`
`24 at 33.
`
`Instead, Petitioner seeks to replace an alleged prior-art reference relied on in
`
`two instituted grounds but still has not filed information with the Board to establish
`
`its public availability, despite Patent Owners’ challenge and the Board’s
`
`encouragement to do so. It is Petitioner’s burden to establish that the reference is a
`
`printed publication. However, nothing in its motion or the Carroll Declaration (Ex.
`
`1045) addresses that issue. Petitioner has waited for Patent Owners (and the
`
`Board, see Paper 24 at 33) to point out a significant flaw—that one of its alleged
`
`prior-art references was not a reference at all, but a combination of unrelated
`
`materials—and then sought to correct it without addressing the heart of the
`
`problem, i.e., its status as prior art. The prior-art references are arguably the most
`
`important part of a petition, and it is especially important for the Board to ensure
`
`that supplemental information is not used to edit them after the fact.
`
`B.
`
`Patent Owners Have Been Prejudiced by Petitioner’s Mistake
`
`As discussed in response to Petitioner’s Motion to Correct, Petitioner has not
`
`made a simple clerical mistake. At the time it submitted its Petition, Petitioner
`
`essentially did not know what prior-art reference it was relying on. And so neither
`
`could Patent Owners or the Board. Patent Owners prepared their Preliminary
`
`Response without knowing what reference Petitioner meant to refer to.
`
`– 4 –
`
`
`
`Petitioner, citing Palo Alto Networks, contends that there is no prejudice
`
`because the textual material contained in Ex. 1010 was the material on which it
`
`intended to rely all along, and so none of its substantive arguments regarding that
`
`material have changed. But the petitioner in Palo Alto Networks sought to submit
`
`supplemental information to support the public availability of two references—not
`
`to change the references themselves. Paper 37 at 2-3, Palo Alto Networks,
`
`IPR2013-00369. Furthermore, Patent Owners could not have known, looking at
`
`hybrid Ex. 1010 (or the citations in the Petition and Park Declaration), that the
`
`textual material provided was the material Petitioner meant to rely on. Patent
`
`Owners cannot effectively contest the public availability or substance of a
`
`reference that Petitioner has not adequately identified.
`
`C.
`
`Petitioner Could Have Discovered Its Mistake Sooner
`
`Petitioner contends that it “could not have anticipated” its mistake until
`
`Patent Owners pointed it out. Paper 32 at 3. But it was Petitioner’s responsibility
`
`to check its alleged prior-art references; a simple check of the fourth edition’s table
`
`of contents would have revealed a substantial mismatch in page numbers. Further,
`
`even after Patent Owner pointed out the problem, Petitioner waited until after
`
`institution to explain it away.
`
`V. CONCLUSION
`
`Petitioner’s Motion to File Supplemental Information should be denied.
`
`– 5 –
`
`
`
`Dated: December 3, 2018
`
`
`
`Customer Number: 24395
`Tel: (202) 663-6028
`Fax: (202) 663-6363
`
`
`
`Respectfully submitted,
`
`By: /Heather M. Petruzzi/
`Heather M. Petruzzi
`Reg. No. 71,270
`WILMER CUTLER PICKERING
` HALE AND DORR LLP
`1875 Pennsylvania Avenue, NW
`Washington, DC 20006
`
`Counsel for Patent Owners Bristol-
`Myers Squibb Co. & Pfizer Inc.
`
`
`– 6 –
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that, on December 3, 2018, I caused a true and correct copy
`
`of Patent Owners’ Opposition to Petitioner’s Motion to File Supplemental
`
`Information Pursuant to 37 C.F.R. § 42.123(a) to be served via electronic mail on
`
`the following attorneys of record and crystalregan@parkerpoe.com:
`
`Micheal L. Binns
`PARKER POE ADAMS & BERNSTEIN LLP
`1180 Peachtree Street, N.E., Suite 3300
`Atlanta, GA 30309
`michealbinns@parkerpoe.com
`
`Robert L. Florence
`PARKER POE ADAMS & BERNSTEIN LLP
`1180 Peachtree Street, N.E., Suite 3300
`Atlanta, GA 30309
`robertflorence@parkerpoe.com
`
`Karen L. Carroll
`PARKER POE ADAMS & BERNSTEIN LLP
`1180 Peachtree Street, N.E., Suite 3300
`Atlanta, GA 30309
`karencarroll@parkerpoe.com
`
`
`
`
`
`
`
`
`Sharad K. Bijanki
`PARKER POE ADAMS & BERNSTEIN LLP
`1180 Peachtree Street, N.E., Suite 3300
`Atlanta, GA 30309
`sharadbijanki@parkerpoe.com
`
`
`
`
`
`
`_/Michael E. Nelson/____________
`Michael E. Nelson
`Reg. No. 64,115
`Wilmer Cutler Pickering Hale and Dorr LLP
`60 State Street
`Boston, MA 02109
`
`